Pipeline
The Science
About us
Investors
News

Hit enter to search or ESC to close

Alterity PBT434 Poster Presented at 2019 MDS Congress

October 3, 2019October 10, 2019 Alterity Therapeutics

Alterity PBT434 Poster – MDS 2019 Congress

Post navigation

Alterity presents clinical data on PBT434 at the 2019 MDS Congress

Quarterly Cash Flow Report

Related Posts

Prana receives A$3.3 million R&D Tax Incentive

March 18, 2019

Prana receives $3 million R&D Tax Incentive Refund

December 19, 2017

Prana EGM and Conference Call Facility

March 27, 2019

Leave a Reply Cancel reply

Your email address will not be published.Required fields are marked *

Save my name, email, and website in this browser for the next time I comment.

Recent Posts

Quarterly Cash Flow Report
ATH434 protects brain cells and improves motor function
Alterity CEO David Stamler presents to US investors at the HC Wainwright Global Life Science Conference
Alterity to present at the 7th International Congress of Multiple System Atrophy
Alterity Half Year Results and Investor Webcast Notification

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065